Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 216890
Company: SANDOZ

Products on ANDA 216890

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TRIAZOLAM	TRIAZOLAM	0.125MG	TABLET;ORAL	Prescription	AB	No	No
TRIAZOLAM	TRIAZOLAM	0.25MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 216890

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/08/2022	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/08/2023	SUPPL-2	Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 216890

TRIAZOLAM

TABLET;ORAL; 0.125MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
HALCION	TRIAZOLAM	0.125MG	TABLET;ORAL	Prescription	Yes	AB	017892	PFIZER
TRIAZOLAM	TRIAZOLAM	0.125MG	TABLET;ORAL	Prescription	No	AB	214219	NOVAST LABS
TRIAZOLAM	TRIAZOLAM	0.125MG	TABLET;ORAL	Prescription	No	AB	216890	SANDOZ
TRIAZOLAM	TRIAZOLAM	0.125MG	TABLET;ORAL	Prescription	No	AB	213003	ZYDUS PHARMS

TABLET;ORAL; 0.25MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
HALCION	TRIAZOLAM	0.25MG	TABLET;ORAL	Prescription	Yes	AB	017892	PFIZER
TRIAZOLAM	TRIAZOLAM	0.25MG	TABLET;ORAL	Prescription	No	AB	214219	NOVAST LABS
TRIAZOLAM	TRIAZOLAM	0.25MG	TABLET;ORAL	Prescription	No	AB	216890	SANDOZ
TRIAZOLAM	TRIAZOLAM	0.25MG	TABLET;ORAL	Prescription	No	AB	213003	ZYDUS PHARMS